Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

L Festino, Gerardo Botti, Paul Lorigan, Giuseppe V. Masucci, Jason D. Hipp, C Horak, I Melero, PA Ascierto

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f2865213d780441b9fb8d124ce8cd750,

title = "Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?",

author = "L Festino and Gerardo Botti and Paul Lorigan and Masucci, {Giuseppe V.} and Hipp, {Jason D.} and C Horak and I Melero and PA Ascierto",

year = "2016",

month = jun,

doi = "10.1007/s40265-016-0588-x",

language = "English",

volume = "76",

pages = "925--945",

journal = "Drugs",

issn = "0012-6667",